Search

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

H5N1: Bird flu again. What’s different now?

H5N1: how is avian influenza now? The virus known for affecting wild & domestic birds has been detected in dairy cows in the US. What you need to know.

Outside the lab…inside the family

We are a manufacturing and a research company too. Outside of the lab, we have engineers, legal teams, logistics managers, QA/QC teams and more.

World Recycling Day: Closing the Loop

Transitioning the economy from a linear to a circular approach herculean task – but also an innovation that carries huge potential

It is about saving lives Alexis Jaliquias feline blood bank

Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America

FDA accepts new chronic kidney disease treatment application

The geography of pet parasites is changing

Climate change facilitates new pet parasites way beyond ticks and flea bites in dogs and cats

Scleroderma Life Hacks

Video series featuring people living with scleroderma using everyday items in different ways to help them manage their symptoms. Part of the global 'More Than Scleroderma' initiative developed by Boehringer Ingelheim, with support from patient organi

FDA- HFpEF-breakthrough-designation-EMPEROR-preserved

U.S. FDA issues Breakthrough Therapy Designation for the treatment of adults with heart failure with preserved ejection fraction

Facts about the INPULSIS™ trials

Cardiometabolic Diseases

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.

AI&Data Science Fellowship Tuebingen

Immunology

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in immunology.

License deal with A*STAR to develop cancer antibodies

About Boehringer Ingelheim Partnering Days

Find out more about our partnering days and how we can work together to accelerate your science

Drug Discovery at Boehringer Ingelheim

Find out more about the drug discovery process at Boehringer Ingelheim

Congress Patient Benefit

The participation in scientific congresses is firmly established in the event agenda of any pharmaceutical company. But what is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical represent

BI Access to Healthcare Strategy_Availability

Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.

Partnership Boehringer Ingelheim Lifebit health data

Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data

Oncology

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in oncology.

Partnering in Retinal Health

Our partnering interests in retinal diseases offer opportunities for collaboration to complement our pipeline and advance treatment and delivery.

Partnering-with-google-in-quantum-computing

New cooperation with Google explores the potentials of quantum computing for pharma R&D.

collaboration-LIBD

Boehringer Ingelheim and The Lieber Institute for Brain Development collaborate on centrally acting COMT inhibitors in neuropsychiatric disorders

SIRPα antagonist

Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim

Explore the potential of big molecules with BioXcellence, offering advanced biopharmaceutical production services to unlock new possibilities in healthcare.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers